{
  "ticker": "AGN",
  "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02971945",
  "id": "02971945",
  "pages": 2,
  "price_sensitive": false,
  "date": "20250723",
  "time": "1548",
  "pdf_url": "https://announcements.asx.com.au/asxpdf/20250723/pdf/06m26zlm7r3kwl.pdf",
  "summary": "- **Substantial Holder Ceasing**: Insignia Financial Ltd (and affiliates) ceased to be a substantial holder in Argenica Therapeutics (AGN) on **16-Jul-2025**.  \n- **Recent Transactions**:  \n  - Net **sell-down** by associates (IOOF/MLC) of **198,456 AGN shares** between 02-Dec-2024 and 16-Jul-2025.  \n  - Prior net purchases of **331,805 AGN shares** from 04-Jul-2024 to 19-Mar-2025.  \n\n*(Note: No ongoing material stake disclosed; monitor for further liquidity impacts.)*",
  "usage": {
    "prompt_tokens": 1060,
    "completion_tokens": 139,
    "total_tokens": 1199,
    "prompt_tokens_details": null
  },
  "model": "deepseek/deepseek-chat-v3-0324:free",
  "processed_at": "2025-07-23T05:53:59.911057"
}